204 related articles for article (PubMed ID: 32519183)
1. Soft tissue sarcoma: can dynamic contrast-enhanced (DCE) MRI be used to predict the histological grade?
Li X; Wang Q; Dou Y; Zhang Y; Tao J; Yang L; Wang S
Skeletal Radiol; 2020 Nov; 49(11):1829-1838. PubMed ID: 32519183
[TBL] [Abstract][Full Text] [Related]
2. Whole-tumor histogram analysis of diffusion-weighted imaging and dynamic contrast-enhanced MRI for soft tissue sarcoma: correlation with HIF-1alpha expression.
Li X; Hu Y; Xie Y; Lu R; Li Q; Tao H; Chen S
Eur Radiol; 2023 Jun; 33(6):3961-3973. PubMed ID: 36462043
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
[TBL] [Abstract][Full Text] [Related]
4. Soft tissue sarcoma: correlation of dynamic contrast-enhanced magnetic resonance imaging features with HIF-1α expression and patient outcomes.
Li X; Xie Y; Hu Y; Lu R; Li Q; Xiong B; Tao H; Chen S
Quant Imaging Med Surg; 2022 Oct; 12(10):4823-4836. PubMed ID: 36185052
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
Lee SK; Jee WH; Jung CK; Chung YG
Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
[TBL] [Abstract][Full Text] [Related]
6. [The value of DCE-MRI in predicting IDH gene mutation of high-grade gliomas].
Lu HT; Xing W; Zhang YW; Qin HP; Wu RH; Ding JL
Zhonghua Yi Xue Za Zhi; 2019 Oct; 99(39):3105-3109. PubMed ID: 31648456
[No Abstract] [Full Text] [Related]
7. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
[TBL] [Abstract][Full Text] [Related]
9. Morphological and dynamic contrast enhanced MR imaging features for the differentiation of chordoma and giant cell tumors in the Axial Skeleton.
Lang N; Su MY; Xing X; Yu HJ; Yuan H
J Magn Reson Imaging; 2017 Apr; 45(4):1068-1075. PubMed ID: 27490009
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
11. Comparison of diffusion kurtosis imaging and dynamic contrast enhanced MRI in prediction of prognostic factors and molecular subtypes in patients with breast cancer.
Wang W; Lv S; Xun J; Wang L; Zhao F; Wang J; Zhou Z; Chen Y; Sun Z; Zhu L
Eur J Radiol; 2022 Sep; 154():110392. PubMed ID: 35679701
[TBL] [Abstract][Full Text] [Related]
12. Can we use MRI to detect clinically silent recurrent soft-tissue sarcoma?
Hirschmann A; van Praag VM; Haas RL; van de Sande MAJ; Bloem JL
Eur Radiol; 2020 Sep; 30(9):4724-4733. PubMed ID: 32314057
[TBL] [Abstract][Full Text] [Related]
13. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D
Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994
[TBL] [Abstract][Full Text] [Related]
14. The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas.
Yuan SJ; Qiao TK; Qiang JW; Cai SQ; Li RK
J Ovarian Res; 2017 Sep; 10(1):65. PubMed ID: 28950890
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced (DCE) MR imaging: the role of qualitative and quantitative parameters for evaluating prostate tumors stratified by Gleason score and PI-RADS v2.
Afshari Mirak S; Mohammadian Bajgiran A; Sung K; Asvadi NH; Markovic D; Felker ER; Lu D; Sisk A; Reiter RE; Raman SS
Abdom Radiol (NY); 2020 Jul; 45(7):2225-2234. PubMed ID: 31549211
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of permeability for glioma grading using dynamic contrast-enhanced magnetic resonance imaging.
Zhao M; Guo LL; Huang N; Wu Q; Zhou L; Zhao H; Zhang J; Fu K
Oncol Lett; 2017 Nov; 14(5):5418-5426. PubMed ID: 29113174
[TBL] [Abstract][Full Text] [Related]
17. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of pathological complete response to neoadjuvant chemotherapy combining DCE-MRI and apparent diffusion coefficient values in breast Cancer.
Liang X; Chen X; Yang Z; Liao Y; Wang M; Li Y; Fan W; Dai Z; Zhang Y
BMC Cancer; 2022 Dec; 22(1):1250. PubMed ID: 36460972
[TBL] [Abstract][Full Text] [Related]
19. Detecting residual soft tissue sarcoma after unplanned excision; model-free analysis of dynamic contrast-enhanced MRI at short-term follow-up.
Ahn H; Lee MH; Byun SH; Kim HJ; Kim W; Chee CG; Chung HW; Yoon MA; Lee SH
Br J Radiol; 2023 Dec; 96(1152):20230410. PubMed ID: 37750840
[TBL] [Abstract][Full Text] [Related]
20. Soft-Tissue Sarcomas: Assessment of MRI Features Correlating with Histologic Grade and Patient Outcome.
Crombé A; Marcellin PJ; Buy X; Stoeckle E; Brouste V; Italiano A; Le Loarer F; Kind M
Radiology; 2019 Jun; 291(3):710-721. PubMed ID: 30964422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]